Welcome to LookChem.com Sign In|Join Free

CAS

  • or

19981-17-0

cyanamide, sodium salt is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

19981-17-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 19981-17-0 Structure

  • Basic information

    1. Product Name: cyanamide, sodium salt
    2. Synonyms: cyanamide, sodium salt;Cyanamide/sodium,(1:x) salt
    3. CAS NO:19981-17-0
    4. Molecular Formula: CHN2*Na
    5. Molecular Weight: 64.02181
    6. EINECS: 243-451-0
    7. Product Categories: N/A
    8. Mol File: 19981-17-0.mol

  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: cyanamide, sodium salt(CAS DataBase Reference)
    10. NIST Chemistry Reference: cyanamide, sodium salt(19981-17-0)
    11. EPA Substance Registry System: cyanamide, sodium salt(19981-17-0)

  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 19981-17-0(Hazardous Substances Data)

19981-17-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 19981-17-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,9,9,8 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 19981-17:
(7*1)+(6*9)+(5*9)+(4*8)+(3*1)+(2*1)+(1*7)=150
150 % 10 = 0
So 19981-17-0 is a valid CAS Registry Number.
InChI:InChI=1/CH2N2.Na/c2-1-3;/h2H2;/q;+1

19981-17-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name cyanamide,sodium

1.2 Other means of identification

Product number -
Other names sodium hydrogencyanamide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:19981-17-0 SDS

19981-17-0Relevant articles and documents

Sulfoxide-to-sulfilimine conversions: Use of modified Burgess-type reagents

Hendriks, Christine M. M.,Lamers, Philip,Engel, Julien,Bolm, Carsten

supporting information, p. 3363 - 3368 (2013/12/04)

Sulfoxides can directly be converted into N-cyanosulfilimines using a new Burgess-type reagent. By applying this strategy with a related reagent variant, synthetically valuable NH-sulfoximines have been prepared from sulfoxides via N-protected sulfilimines. The practical three-step reaction sequence is generally high yielding and applicable to a wide range of substrates. The sulfoxide-to-sulfilimine conversion can also be performed under solvent-reduced conditions in a ball mill. Copyright

Compounds derived from an amine nucleus and pharmaceutical compositions comprising same

-

, (2008/06/13)

Compounds having the formula (I), are effective as inhibitors of IMPDH enzyme and/or serine protease Factor VIIa, wherein B is a monocyclic or bicyclic carbocyclic or heterocyclic ring, D is a monocyclic or bicyclic carbocyclic or heterocyclic ring except when A is a heterocyclic ring, then D is a heterocyclic ring system, R is hydrogen or C1-4alkyl, and A, R1, R2and R4are as defined in the specification.

Compounds derived from an amine nucleus and pharmaceutical compositions comprising same

-

, (2008/06/13)

Compounds having the formula (I), are effective as inhibitors of IMPDH enzyme and/or serine protease Factor VIIa, wherein B is a monocyclic or bicyclic carbocyclic or heterocyclic ring, D is a monocyclic or bicyclic carbocyclic or heterocyclic ring except when A is a heterocyclic ring, then D is a heterocyclic ring system, R is hydrogen or C1-4alkyl, and A, R1, R2 and R4 are as defined in the specification.

Compounds derived from an amine nucleus that are inhibitors of IMPDH enzyme

-

, (2008/06/13)

The present invention discloses the identification of the novel inhibitors of IMPDH (inosine-5′-monophosphate dehydrogenase). The compounds and pharmaceutical compositions disclosed herein are useful in treating or preventing IMPDH mediated diseases, such as transplant rejection and autoimmune diseases.

Inhibitors of IMPDH enzyme

-

, (2008/06/13)

The present invention discloses the identification of the novel inhibitors of IMPDH (inosine-5′-monophosphate dehydrogenase). The compounds and pharmaceutical compositions disclosed herein are useful in treating or preventing IMPDH-associated disorders, such as transplant rejection and autoimmune diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 19981-17-0